Congressional trades by ticker
MRK congressional trades
- Verified rows
- 41
- Filers
- 16
- Purchases
- 20
- Latest trade
- 2026-08-19
Verified MRK House disclosures
Parsed from official House Clerk periodic transaction reports. This snapshot contains 20 purchases and 21 sales. Reported owners: Self, Joint, Spouse, Dependent. Transaction dates run from 2024-08-07 to 2026-08-19.
| Politician | Trade date | Asset | Type | Owner | Amount | Filing |
|---|---|---|---|---|---|---|
| Maria Salazar | Merck & Company, Inc. Common Stock | Purchase | Self | $15,001 - $50,000 | #20035411 Filed 2026-09-09 | |
| Maria Salazar | Merck & Company, Inc. Common Stock | Purchase | Self | $15,001 - $50,000 | #20035411 Filed 2026-09-09 | |
| Josh Gottheimer | Merck & Company, Inc. Common Stock | Purchase | Joint | $1,001 - $15,000 | #20034130 Filed 2026-03-16 | |
| Gilbert Cisneros | Merck & Company, Inc. Common Stock | Purchase | Self | $1,001 - $15,000 | #20033762 Filed 2026-01-12 | |
| Julie Johnson | Merck & Company, Inc. Common Stock | Sale | Joint | $1,001 - $15,000 | #20033789 Filed 2026-01-15 | |
| Gilbert Cisneros | Merck & Company, Inc. Common Stock | Purchase | Self | $1,001 - $15,000 | #20033619 Filed 2025-12-15 | |
| Julie Johnson | Merck & Company, Inc. Common Stock | Sale | Joint | $1,001 - $15,000 | #20033611 Filed 2025-12-11 | |
| Valerie Hoyle | Merck & Company, Inc. Common Stock | Sale | Spouse | $1,001 - $15,000 | #20032211 Filed 2025-10-10 | |
| Marjorie Greene | Merck & Company, Inc. Common Stock | Purchase | Self | $1,001 - $15,000 | #20030996 Filed 2025-08-29 | |
| Julie Johnson | Merck & Company, Inc. Common Stock | Sale | Joint | $1,001 - $15,000 | #20032066 Filed 2025-09-11 | |
| Gilbert Cisneros | Merck & Company, Inc. Common Stock | Purchase | Self | $1,001 - $15,000 | #20031022 Filed 2025-09-12 | |
| Lisa McClain | Merck & Company, Inc. Common Stock | Sale | Spouse | $1,001 - $15,000 | #20030932 Filed 2025-09-12 | |
| Ritchie Torres | C: This investment is held within a publicly available, widely held independently managed portfolio over which I have no authority to exercise control over or influence the financial interests held by the portfolio. The assets of the portfolio are widely diversified, and all investment decisions are made solely by the independent manager, without my input or direction. Merck & Company, Inc. Common Stock | Sale | Self | $1,001 - $15,000 | #20030930 Filed 2025-08-20 | |
| Lisa McClain | Merck & Company, Inc. Common Stock | Purchase | Spouse | $1,001 - $15,000 | #20030891 Filed 2025-08-13 | |
| C. Franklin | Merck & Company, Inc. Common Stock | Sale | Joint | $1,001 - $15,000 | #20030670 Filed 2025-07-14 | |
| Julie Johnson | Merck & Company, Inc. Common Stock | Purchase | Joint | $1,001 - $15,000 | #20030647 Filed 2025-07-14 | |
| Gilbert Cisneros | Merck & Company, Inc. Common Stock | Sale | Self | $1,001 - $15,000 | #20030461 Filed 2025-06-06 | |
| Robert Bresnahan | Merck & Company, Inc. Common Stock | Sale | Self | $15,001 - $50,000 | #20030433 Filed 2025-05-31 | |
| Marjorie Greene | Merck & Company, Inc. Common Stock | Purchase | Self | $1,001 - $15,000 | #20030295 Filed 2025-05-06 | |
| Gilbert Cisneros | Merck & Company, Inc. Common Stock | Purchase | Self | $1,001 - $15,000 | #20030288 Filed 2025-05-06 | |
| Bruce Westerman | Merck & Company, Inc. Common Stock | Sale | Self | $1,001 - $15,000 | #20030332 Filed 2025-05-12 | |
| Jefferson Shreve | Merck & Company, Inc. Common Stock | Sale | Self | $15,001 - $50,000 | #20030231 Filed 2025-05-08 | |
| Marjorie Greene | Merck & Company, Inc. Common Stock | Purchase | Self | $1,001 - $15,000 | #20029138 Filed 2025-04-11 | |
| Robert Bresnahan | Merck & Company, Inc. Common Stock | Purchase | Self | $15,001 - $50,000 | #20030291 Filed 2025-05-08 | |
| Gilbert Cisneros | Merck & Company, Inc. Common Stock | Sale | Self | $15,001 - $50,000 | #20029026 Filed 2025-04-07 | |
| Kelly Morrison | Merck & Company, Inc. Common Stock | Sale | Self | $1,001 - $15,000 | #20029121 Filed 2025-04-11 | |
| Sheri Biggs | Merck & Company, Inc. Common Stock | Sale | Spouse | $15,001 - $50,000 | #20032149 Filed 2025-10-05 | |
| Bruce Westerman | Merck & Company, Inc. Common Stock | Purchase | Self | $1,001 - $15,000 | #20030146 Filed 2025-04-16 | |
| Gilbert Cisneros | Merck & Company, Inc. Common Stock | Purchase | Self | $15,001 - $50,000 | #20027891 Filed 2025-03-06 | |
| Robert Bresnahan | Merck & Company, Inc. Common Stock | Sale | Self | $15,001 - $50,000 | #20029034 Filed 2025-03-27 | |
| Jefferson Shreve | Merck & Company, Inc. Common Stock | Purchase | Self | $15,001 - $50,000 | #20027879 Filed 2025-03-09 | |
| Josh Gottheimer | Merck & Company, Inc. Common Stock | Sale | Joint | $15,001 - $50,000 | #20026732 Filed 2025-02-10 | |
| Gilbert Cisneros | Merck & Company, Inc. Common Stock | Sale | Self | $1,001 - $15,000 | #20026726 Filed 2025-02-11 | |
| Julie Johnson | Merck & Company, Inc. Common Stock | Purchase | Joint | $1,001 - $15,000 | #20026762 Filed 2025-02-12 | |
| Byron Donalds | Merck & Company, Inc. Common Stock | Sale | Self | $1,001 - $15,000 | #20026712 Filed 2025-02-10 | |
| Byron Donalds | Merck & Company, Inc. Common Stock | Sale | Spouse | $1,001 - $15,000 | #20026712 Filed 2025-02-10 | |
| Jared Moskowitz | Merck & Company, Inc. Common Stock | Sale | Dependent | $1,001 - $15,000 | #20026731 Filed 2025-02-10 | |
| Jared Moskowitz | Merck & Company, Inc. Common Stock | Sale | Dependent | $1,001 - $15,000 | #20026731 Filed 2025-02-10 | |
| Valerie Hoyle | Merck & Company, Inc. Common Stock | Purchase | Spouse | $1,001 - $15,000 | #20032070 Filed 2025-09-12 | |
| Ritchie Torres | C: This investment is held within a publicly available, widely held independently managed portfolio over which I have no authority to exercise control over or influence the financial interests held by the portfolio. The assets of the portfolio are widely diversified, and all investment decisions are made solely by the independent manager, without my input or direction. Merck & Company, Inc. Common Stock | Purchase | Self | $1,001 - $15,000 | #20030930 Filed 2025-08-20 | |
| C. Franklin | C: Our broker purchased shares of 29 stocks in my spouse's Roth IRA on 8/7/24 in order to rebalance the portfolio in accordance with the firm's investment strategy for accounts that size. He failed to notify me of these transactions and it wasn't discovered until I was attempting to reconcile our investment holdings for my 2024 Financial Disclosure. Merck & Company, Inc. Common Stock | Purchase | Spouse | $1,001 - $15,000 | #20030494 Filed 2025-07-03 |
A filing can describe the member, a spouse, a dependent, or a joint asset. Amounts are statutory ranges, not execution prices. See how to read congressional stock-trade disclosures before treating a delayed row as a trading signal.
The filing is free
Keep the MRK range and owner as filed. Membership adds the investment view around the money, not a list to copy.
Related research
MRK congressional trades — FAQ
Who in Congress traded MRK?
House Clerk periodic reports for 2025 and 2026 contain 41 verified MRK rows from 16 members: Bruce Westerman, Byron Donalds, C. Franklin, Gilbert Cisneros, and 12 other members. Image-only filings are excluded, and this is not a live brokerage statement.
Does this page show current MRK holdings?
No. STOCK Act filings disclose reportable transactions after the fact, usually within 45 days, as amount ranges and owners. They do not prove a current position, an exact share count, or why the trade happened.
Why are MRK amounts shown as ranges?
House periodic transaction reports use statutory value bands such as $15,001 - $50,000; $1,001 - $15,000. Yield Theory keeps those ranges instead of inventing a midpoint, exact trade size, or return.
How complete is MRK congressional-trade coverage?
This snapshot covers every machine-readable House periodic transaction report for 2025 and 2026 (142 members). Image-only filings and Senate eFD filings are not included, so missing rows are not proof that no other lawmaker traded MRK.
Yield Theory is not affiliated with any elected official. This page uses the 2025–2026 House Clerk periodic report snapshot generated 2026-09-20. It is not a complete lifetime portfolio, a performance track record, or investment advice.
A disclosure is not a thesis.
This page shows who reported MRK and in what range. Membership is the monthly sourced call, plus a five-minute check when the evidence moves. $15/month or $150/year.
$15/mo or $150/yr · cancel future renewals anytime · sources included